Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: A longitudinal French cohort study
Open accessAbstract
Oncogenic HPV types are the major cause of worldwide cervical cancer, but only a small proportion of infected women will develop high‐grade cervical intraepithelial neoplasia or cancer (CIN2/3+). We performed a prospective study including 781 women with normal, atypical squamous cells of undetermined significance (ASCUS) or low‐grade squamous intraepithelial lesion (LGSIL) cytology, and infected or not by high‐risk (HR) HPV tested by Hybrid Capture II. Women were followed up every 6 months for a median period of 22 months. Among the HR‐HPV‐positive women at entry, more than half cleared their virus in 7.5 months; the clearance rate was greater for low viral loads than for high loads and also was higher in women with an initial ASCUS/LGSIL smear than in women with normal cytology. The incidence of cytologic abnormalities strongly depended on baseline viral load and HR‐HPV persistence. Maintenance of cytologic abnormalities was associated with the outcome of HR‐HPV status (negative<transient<persistent) but not with baseline load. Progression to CIN2/3+ was achieved only in women with persistent HR‐HPV infection. The risk of CIN2/3+ also was increased with initial high loads (≥100 pg/mL). Conversely, women who were consistently HR‐HPV negative or transiently HR‐HPV positive, whatever the cytology at baseline was, did not develop CIN2/3+ during follow‐up. Age seemed to affect only the rate of incident HR‐HPV infection. In conclusion, our data suggest that women repeatedly tested positive for HR‐HPV are at risk of developing CIN2/3+, even when initial cytology is normal. A high viral load could be used as a short‐term marker of progression toward precancerous lesions, although lower load does not inevitably exclude progressive disease. © 2003 Wiley‐Liss, Inc.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The prognostic significance of HR-HPV viral load in cervical cancer remains controversial.
“The prognostic significance of HR-HPV viral load in cervical cancer remains controversial.”
From Comparative evaluation of Allplex HPV28 and Anyplex II HPV28 assays for high-risk HPV genotyping in cervical samples (2025) · cites this paper as [14]
The Discussion reports conflicting findings on whether HR-HPV load predicts development of high-grade cervical lesions, supporting the claim that its prognostic value is debated. The paper studies progression to CIN2/3+, not prognosis in patients with cervical cancer, so the claim extends beyond its evidence. (LLM, conf=0.86)
Experimental — accuracy not yet measuredStrict cut-offs may potentially miss low-level infections, even though such infections are not necessarily clinically significant.
“This highlights the importance of carefully evaluating the cut-offs used for cervical cancer screening and HPV infection monitoring, as strict cut-offs may potentially miss low-level infections, even though such infections are not necessarily clinically significant [14].”
From Comparative evaluation of Allplex HPV28 and Anyplex II HPV28 assays for high-risk HPV genotyping in cervical samples (2025) · cites this paper as [14]
The Methods passage (page unavailable) defines HPV positivity using an HCII ratio of at least 1, but the paper does not test whether stricter cut-offs miss low-level infections. The Discussion reports that low-load infections were more likely to clear, supporting the qualified point that they are not necessarily clinically significant; it also cautions that low load does not exclude progressive disease. (LLM, conf=0.83)
Experimental — accuracy not yet measuredPrevious studies have reported an association between increased HR-HPV viral load and the severity and progression of cervical lesions.
“Previous studies have reported an association between increased HR-HPV viral load and the severity and progression of cervical lesions [13,14]”
From Comparative evaluation of Allplex HPV28 and Anyplex II HPV28 assays for high-risk HPV genotyping in cervical samples (2025) · cites this paper as [14]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Persistent Human Papillomavirus Infection as a Predictor of Cervical Intraepithelial Neoplasia
Schlecht, N. F. (2001) · JAMA · doi:10.1001/jama.286.24.3106 · Cited by 590 · see citing works
Flagged first, then by citations
Research works printed but not linked: 46
- zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002;2:342-50.
- Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Mun ˜oz N. Human papillo- mavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9.
- Bosch FX, Manos MM, Muñoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J Natl Cancer Inst 1995;87:796 -802.
- Ho GY, Burk RD, Klein S, Kadish AS, Chang CJ, Palan P, Basu J, Tachezy R, Lewis R, Romney S. Persistent genital human papilloma- virus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995;87:1365-71.
- Riethmuller D, Gay C, Bertrand X, Bettinger D, Schaal JP, Car- billet JP, Lassabe C, Arveux P, Seilles E, Mougin C. Genital human papillomavirus infection among women recruited for rou- tine cervical cancer screening or for colposcopy determined by Hybrid Capture II and polymerase chain reaction. Diagn Mol Pathol 1999;8:157-64.
- Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338:423-8.
- Woodman CB, Collins S, Winter H, Bailey A, Ellis J, Prior P, Yates M, Rollason TP, Young LS. Natural history of cervical human pap- illomavirus infection in young women: a longitudinal cohort study. Lancet 2001;357:1831-6.
- Dillner J, Lehtinen M, Bjorge T, Luostarinen T, Youngman L, Jellum E, Koskela P, Gislefoss RE, Hallmans G, Paavonen J, Sapp M, Schiller JT, et al. Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer. J Natl Cancer Inst 1997;89:1293-9.
- Wallin KL, Wiklund F, Angstrom T, Bergman F, Stendahl U, Wadell G, Hallmans G, Dillner J. Type-specific persistence of human papil- lomavirus DNA before the development of invasive cervical cancer. N Engl J Med 1999;341:1633-8.
- Zielinski GD, Snijders PJ, Rozendaal L, Voorhorst FJ, van der Linden HC, Runsink AP, de Schipper FA, Meijer CJ. HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears. Br J Cancer 2001;85:398 -404.
- Koutsky LA, Holmes KK, Critchlow CW, Stevens CE, Paavonen J, Beckmann AM, DeRouen TA, Galloway DA, Vernon D, Kiviat NB. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992;327: 1272-8.
- Remmink AJ, Walboomers JM, Helmerhorst TJ, Voorhorst FJ, Ro- zendaal L, Risse EK, Meijer CJ, Kenemans P. The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer 1995;61:306 -11.
- Nobbenhuis MA, Walboomers JM, Helmerhorst TJ, Rozendaal L, Remmink AJ, Risse EK, van der Linden HC, Voorhorst FJ, Kenemans P, Meijer CJ. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet 1999;354:20 -5.
- Nobbenhuis MA, Helmerhorst TJ, van den Brule AJ, Rozendaal L, Voorhorst FJ, Bezemer PD, Verheijen RH, Meijer CJ. Cytological regression and clearance of high-risk human papillomavirus in women with an abnormal cervical smear. Lancet 2001;358:1782-3.
- Meijer CJ, Helmerhorst TJ, Rozendaal L, van der Linden JC, Voor- horst FJ, Walboomers JM. HPV typing and testing in gynaecological pathology: has the time come? Histopathology 1998;33:83-6.
- Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244 -65.
- Cain JM, Howett MK. Preventing cervical cancer. Science 2000;288: 1753-5.
- Herbst AL, Pickett KE, Follen M, Noller KL. The management of ASCUS cervical cytologic abnormalities and HPV testing: a caution- ary note. Obstet Gynecol 2001;98:849 -51.
- Josefsson AM, Magnusson PK, Ylitalo N, Sorensen P, Qwarforth- Tubbin P, Andersen PK, Melbye M, Adami HO, Gyllensten UB. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet 2000; 355:2189 -93.
- Sun CA, Lai HC, Chang CC, Neih S, Yu CP, Chu TY. The signifi- cance of human papillomavirus viral load in prediction of histologic severity and size of squamous intraepithelial lesions of uterine cervix. Gynecol Oncol 2001;83:95-9.
- Sun CA, Liu JF, Wu DM, Nieh S, Yu CP, Chu TY. Viral load of high-risk human papillomavirus in cervical squamous intraepithelial lesions. Int J Gynaecol Obstet 2002;76:41-7.
- van Duin M, Snijders PJ, Schrijnemakers HF, Voorhorst FJ, Ro- zendaal L, Nobbenhuis MA, van den Brule AJ, Verheijen RH, Helmerhorst TJ, Meijer CJ. Human papillomavirus 16 load in normal and abnormal cervical scrapes: an indicator of CIN II/III and viral clearance. Int J Cancer 2002;98:590 -5.
- Clavel C, Masure M, Levert M, Putaud I, Mangeonjean C, Lorenzato M, Nazeyrollas P, Gabriel R, Quereux C, Birembaut P. Human papillomavirus detection by the hybrid capture II assay: a reliable test to select women with normal cervical smears at risk for developing cervical lesions. Diagn Mol Pathol 2000;9:145-50.
- Lorincz AT, Castle PE, Sherman ME, Scott DR, Glass AG, Wacholder S, Rush BB, Gravitt PE, Schussler JE, Schiffman M. Viral load of human papillomavirus and risk of CIN3 or cervical cancer. Lancet 2002;360:228 -9.
- Bory JP, Cucherousset J, Lorenzato M, Gabriel R, Quereux C, Birembaut P, Clavel C. Recurrent human papillomavirus infection detected with the hybrid capture II assay selects women with normal cervical smears at risk for developing high grade cervical lesions: a longitudinal study of 3,091 women. Int J Cancer 2002; 102:519 -25.
- Lorincz A. Hybrid Capture method for detection of human papillo- mavirus DNA in clinical specimens. Papillomavirus Rep 1996;7:1-5.
- Rousseau MC, Pereira JS, Prado JC, Villa LL, Rohan TE, Franco EL. Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection. J Infect Dis 2001;184:1508 -17.
- Franco EL, Villa LL, Sobrinho JP, Prado JM, Rousseau MC, Desy M, Rohan TE. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis 1999;180:1415-23.
- Castellsague ´X, Menendez C, Loscertales MP, Kornegay JR, dos Santos F, Gomez-Olive FX, Lloveras B, Abarca N, Vaz N, Barreto A, Bosch FX, Alonso P. Human papillomavirus genotypes in rural Mozambique. Lancet 2001;358:1429 -30.
- Infantolino C, Fabris P, Infantolino D, Biasin MR, Venza E, Tositti G, Minucci D. Usefulness of human papilloma virus testing in the screening of cervical cancer precursor lesions: a retrospective study in 314 cases. Eur J Obstet Gynecol Reprod Biol 2000;93:71-5.
- Peyton CL, Gravitt PE, Hunt WC, Hundley RS, Zhao M, Apple RJ, Wheeler CM. Determinants of genital human papillomavirus detec- tion in a US population. J Infect Dis 2001;183:1554 -64.
- Hildesheim A, Herrero R, Castle PE, Wacholder S, Bratti MC, Sher- man ME, Lorincz AT, Burk RD, Morales J, Rodriguez AC, Helgesen K, Alfaro M, et al. HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica. Br J Cancer 2001;84:1219 -26.
- Broker TR, Jin G, Croom-Rivers A, Bragg SM, Richardson M, Chow LT, Vermund SH, Alvarez RD, Pappas PG, Squires KE, Hoesley CJ. Viral latency-the papillomavirus model. Dev Biol 2001;106:443-51.
- Wheeler CM, Greer CE, Becker TM, Hunt WC, Anderson SM, Manos MM. Short-term fluctuations in the detection of cervical human pap- illomavirus DNA. Obstet Gynecol 1996;88:261-8.
- Hildesheim A, Schiffman MH, Gravitt PE, Glass AG, Greer CE, Zhang T, Scott DR, Rush BB, Lawler P, Sherman ME, Kurman RJ, Manos MM. Persistence of type-specific human papillomavirus infec- tion among cytologically normal women. J Infect Dis 1994;169:235- 40.
- Moscicki AB, Hills N, Shiboski S, Powell K, Jay N, Hanson E, Miller S, Clayton L, Farhat S, Broering J, Darragh T, Palefsky J. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA 2001; 285:2995-3002.
- Petry KU, Bohmer G, Iftner T, Davies P, Brummer O, Kuhnle H. Factors associated with an increased risk of prevalent and incident grade III cervical intraepithelial neoplasia and invasive cervical can- cer among women with Papanicolaou tests classified as grades I or II cervical intraepithelial neoplasia. Am J Obstet Gynecol 2002;186:28 - 34.
- Cuzick J, Terry G, Ho L, Hollingworth T, Anderson M. Human papillomavirus type 16 in cervical smears as predictor of high-grade cervical intraepithelial neoplasia [corrected]. Lancet 1992;339:959 - 60.
- Bavin PJ, Giles JA, Deery A, Crow J, Griffiths PD, Emery VC, Walker PG. Use of semi-quantitative PCR for human papillomavirus DNA type 16 to identify women with high grade cervical disease in a population presenting with a mildly dyskaryotic smear report. Br J Cancer 1993;67:602-5.
- Sherman ME, Schiffman M, Cox JT. Effects of age and human papilloma viral load on colposcopy triage: data from the randomized Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS). J Natl Cancer Inst 2002;94:102-7.
- Farthing A, Masterson P, Mason WP, Vousden KH. Human papillo- mavirus detection by hybrid capture and its possible clinical use. J Clin Pathol 1994;47:649 -52.
- Sun XW, Ferenczy A, Johnson D, Koulos JP, Lungu O, Richart RM, Wright TC Jr. Evaluation of the Hybrid Capture human papillomavi- rus deoxyribonucleic acid detection test. Am J Obstet Gynecol 1995; 173:1432-7.
- Castle PE, Lorincz AT, Mielzynska-Lohnas I, Scott DR, Glass AG, Sherman ME, Schussler JE, Schiffman M. Results of human papillo- mavirus DNA testing with the hybrid capture 2 assay are reproducible. J Clin Microbiol 2002;40:1088 -90.
- O ¨stör AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 1993;12:186 -92.
- Melnikow J, Nuovo J, Willan AR, Chan BK, Howell LP. Natural history of cervical squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol 1998;92:727-35.
- Holowaty P, Miller AB, Rohan T, To T. Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst 1999;91:252-8.
Cited by
Sorted by citations
Bacterial vaginosis is conducive to the persistence of HPV infection
Guo, Y.-L., You, K., Qiao, J., Zhao, Y.-M., & Geng, L. (2012) · International Journal of STD & AIDS · doi:10.1258/ijsa.2012.011342 · Cited by 116 · see citing works
Mafi, S., Theuillon, F., Meyer, S., Woillard, J.-B., Dupont, M., Rogez, S., Alain, S., & Hantz, S. (2025) · PLOS ONE · doi:10.1371/journal.pone.0320978 · Cited by 9 · see citing works
“This highlights the importance of carefully evaluating the cut-offs used for cervical cancer screening and HPV infection monitoring, as strict cut-offs may potentially miss low-level infections, even though such infections are not necessarily clinically significant [14].”
- Authors
- Dalstein, V., Riethmuller, D., Prétet, J., Le Bail Carval, K., Sautière, J., Carbillet, J., Kantelip, B., Schaal, J., & Mougin, C.
- Affiliations
- Centre Hospitalier Universitaire de Besançon (FR)
- Corresponding author
- Mougin, Christiane
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2003-05-16
- Volume
- 106
- Issue
- 3
- Pages
- 396-403
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2054407949
- Cited by
- 435
- References
- 1
- Citations by year
- 2026: 9 · 2025: 8 · 2024: 12 · 2023: 10 · 2022: 11 · 2021: 16 · 2020: 11 · 2019: 12 · 2018: 10 · 2017: 12 · 2016: 19 · 2015: 21 · 2014: 25 · 2013: 27 · 2012: 21
- FWCI
- 18.56
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- International Journal of Cancer (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- Ligue Contre le Cancer, Comité du Doubs
- Topics
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
- Keywords
- high-risk HPV, persistent HPV infection, viral load, high-grade cervical intraepithelial neoplasia, cervical cancer, HPV clearance, ASCUS, cervical cytology, precancerous lesions
- MeSH terms
- Adolescent, Adult, Aged, Carcinoma, Squamous Cell, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Cervix Uteri, DNA, Viral, False Negative Reactions, False Positive Reactions, Female, France, Humans, Longitudinal Studies, Middle Aged, Prospective Studies, Risk Factors, Tumor Virus Infections, Vaginal Smears, Cohort Studies, Incidence, Viral Load, Papillomaviridae, Papillomavirus Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review